| Intrinsic Valuation of: CRWD | |||||||||||
| Free Cash Flow Average and Growth over past 5Y | Key Statistics | ||||||||||
| Year | FCF | FCF (FCF/Revenue) | |||||||||
| 2020 | - | - | EPS (FY) | -1 | Market Cap | $123B | |||||
| 2021 | - | - (-) | P/E Ratio | - | Total Asset | $9B | |||||
| 2022 | $441M | - (-) | Net Income | $-19M | Total Debt | $744M | |||||
| 2023 | $675M | 52.9% (-1.0%) | EBITDA | $295M | Total Liab | $5B | |||||
| 2024 | $929M | 37.7% (1.0%) | Opr Margin | -0.03 | Debt/Equity | 0.22 | |||||
| 2025 | $1B | 14.9% (-11.2%) | PreTax Margin | -3.71 | BV/Share | 9 | |||||
| 5Y Average FCF | $778M | 35.2% (-3.7%) | |||||||||
| Overall Market Assumptions: | |||||||||||
| Assumptions: | P/E for No-Growth Company: | 7.0 | |||||||||
| Perpetual Growth Rate (g): | 2.5% | Historical US Bond Yield: | 4.4% | ||||||||
| Discount Rate (WACC): | 7.4% | Current US Bond Yield: | 3.5% | ||||||||
| Forcasting Future Free Cash Flow for next 6Y | Modified Benjamin Graham's Intrinsic Value | ||||||||||
| Year | FCF Projection (25.0%) | ||||||||||
| 2026 | $1B | MBG Intrinsic Value | $-6 | ||||||||
| 2027 | $2B | ||||||||||
| 2028 | $2B | ||||||||||
| 2029 | $3B | ||||||||||
| 2030 | $3B | ||||||||||
| 2031 | $4B | ||||||||||
| Terminal Value | $85B | Net Worth/Share | $13 | ||||||||
| DCF Valuation | DCF Valuation "What If" Scenario Table | ||||||||||
| Enterprise Value | $66B | Growth Rate | |||||||||
| (+) Cash & Cash Equivalents | $4B | $281 | 1.5% | 2.0% | 2.5% | 3.0% | 3.5% | ||||
| (-) Total Debt | $744M | WACC | 7.3% | 246 | 264 | 287 | 314 | 349 | |||
| Equity Value | $70B | 7.4% | 244 | 262 | 284 | 310 | 344 | ||||
| Shares Outstanding | 249,248,000 | 7.4% | 241 | 259 | 281 | 307 | 340 | ||||
| 7.9% | 222 | 237 | 254 | 275 | 300 | ||||||
| DCF Intrinsic Value | $281 | 8.4% | 205 | 217 | 232 | 249 | 269 | ||||
| Analyzed by QuantJuice (2025) | |||||||||||